177 results
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
in the Merger — Payment Upon Termination of Employment Following Change of Control;”
The payment of a pro-rated 2024 annual bonus at target performance … of Control;”
The payment of a pro-rated 2024 annual bonus at target performance; and
Continued indemnification and directors’ and officers’ liability
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
annual bonus at target performance; and
Continued indemnification and directors’ and officers’ liability insurance to be provided by the Surviving … bonus at target performance; and
Continued indemnification and directors’ and officers’ liability insurance to be provided by the Surviving
DEFA14A
IMGN
Immunogen, Inc.
21 Dec 23
Additional proxy soliciting materials
3:54pm
, these payments remain confidential between the affected employees and ImmunoGen.
Will my pay change (base compensation, bonus, commission, etc.)? How will my … benefits be affected?
Between now and the closing, your compensation and benefits will remain the same. The annual bonus for the fiscal year ending
DEFA14A
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:08pm
bonus that is at least as favorable as that provided to you at closing, as well as employee benefits that are at least as favorable in the aggregate
DEFA14A
EX-2.1
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:07pm
in control or similar transaction.
(b) At any time prior to the Effective Time, the Company may pay to each designated employee a bonus … equity, severance, separation, retention, employment, individual consulting, change in control, bonus, incentive, deferred compensation, pension
8-K
EX-2.1
lf0pjd js2inq5fscb
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
8-K
jnu3g43o4o
18 Sep 23
ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer
6:35am
8-K
tcbavqtnyio zwz0xii
28 Dec 22
ImmunoGen Announces Susan Altschuller on FMLA Leave; Interim CFO Appointed
4:40pm
8-K
EX-10.1
gap3wsjbciroo1ii
18 Dec 20
Entry into a Material Definitive Agreement
5:19pm
8-K
0zkt39341ai9l1qn 4ms
26 Oct 20
Departure of Directors or Certain Officers
9:22am